Upload
therunner86
View
60
Download
1
Embed Size (px)
DESCRIPTION
Fertility Focus, Inc. Develops product for use in cattle production. Our Product EmGarde increases fertility in the Embryo Transfer Process up to 20%.
Citation preview
Fertility FocusEnhancing the nation’s herd
Multiple
Ovulation
Embryo
Transfer
500,000 embryos transferred world-wide
249,000 in North America
53,000 donor cows
The Problem
58% pregnancy rate
Prostaglandin
(PGF2alpha)
Binding retards development
Uterus
PGF2α
The Solution:
2 ml 1 ltr+
US Patent # 7,075,197Canada # 2,594,358
PGF Receptor Antagonist
PGF2α
Uterus
The Value Proposition
15% increased fertility
• Up to 50 pregnancies
per donor per year
• $75,000 value
The Market
Worldwide - $168 million
N. America - $78.9 million
Total IVF and MOET available market
Market Strategy
Distributors
Personal Networks
Trade Shows and Conferences:• National Cattlemen’s Beef Association
• American Embryo Transfer Association
Website
Timeline
2013 2014 2015
Company
Formed
License
Agreement
Business
Model
Initial
Production
Angel
Round
$150k
SBIR
proposal
$1m
Revenue
Release
Lyophilized
Product
Release
IVF
Product
$1.8m
Revenue
Validations
• License Agreement with UTRF
• Facility Use Agreement with UTAI
• Co-Founded with Tech 20/20
• Initial Product Introduction
• Inventors/researchers on Team
The TeamNeal Schrick, PhD – Chairman
• Dean UT Animal Sciences
Lannett Edwards, PhD – CTO• Lead researcher on cloning
Shawn Carson, MBA – President• Tech 20/20
David Snider, CPA – CFO• Tech20/20